To include your compound in the COVID-19 Resource Center, submit it here.

Takeda venture arm invests in Fate

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) said its Takeda Ventures Inc. venture arm made an undisclosed equity investment in regenerative

Read the full 199 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE